These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

51 related items for PubMed ID: 9695747

  • 1. Functional analysis of tumor-infiltrating leukocytes in breast cancer patients.
    Wong PY, Staren ED, Tereshkova N, Braun DP.
    J Surg Res; 1998 Apr; 76(1):95-103. PubMed ID: 9695747
    [Abstract] [Full Text] [Related]

  • 2. Natural cytotoxicity of lymphocytes from lymph nodes draining breast carcinoma and its augmentation by interferon and OK432.
    Yanagawa E, Uchida A, Micksche M.
    Cancer Immunol Immunother; 1984 Apr; 17(1):1-6. PubMed ID: 6563940
    [Abstract] [Full Text] [Related]

  • 3. Analysis of the immune reactivity of infiltrating and peripheral lymphocytes from patients with renal cell carcinoma by measuring cytokine secretion.
    Elsässer-Beile U, Wetterauer U, Schultze-Seemann W, Gallati H, Mönting JS, von Kleist S.
    Cancer Immunol Immunother; 1996 Feb; 42(2):93-8. PubMed ID: 8620526
    [Abstract] [Full Text] [Related]

  • 4. Cellular characteristics of peripheral blood lymphocytes and tumour-infiltrating lymphocytes in patients with gynaecological tumours.
    Schöndorf T, Engel H, Lindemann C, Kolhagen H, von Rücker AA, Mallmann P.
    Cancer Immunol Immunother; 1997 Apr; 44(2):88-96. PubMed ID: 9177470
    [Abstract] [Full Text] [Related]

  • 5. Lysis by interleukin 2-stimulated tumor-infiltrating lymphocytes of autologous and allogeneic tumor target cells.
    Radrizzani M, Gambacorti-Passerini C, Parmiani G, Fossati G.
    Cancer Immunol Immunother; 1989 Apr; 28(1):67-73. PubMed ID: 2462469
    [Abstract] [Full Text] [Related]

  • 6. CD4+ T lymphocytes infiltrating human breast cancer recognise autologous tumor in an MHC-class-II restricted fashion.
    Dadmarz R, Sgagias MK, Rosenberg SA, Schwartzentruber DJ.
    Cancer Immunol Immunother; 1995 Jan; 40(1):1-9. PubMed ID: 7828162
    [Abstract] [Full Text] [Related]

  • 7. Lymphocytes infiltrating colorectal cancer have low proliferative capacity but can secrete normal levels of interferon gamma.
    Bateman WJ, Donnellan I, Fraser IA, Wong LS, Morris AG.
    Cancer Immunol Immunother; 1995 Jul; 41(1):61-7. PubMed ID: 7641220
    [Abstract] [Full Text] [Related]

  • 8. Evidence for immune defects in breast and lung cancer patients.
    Caras I, Grigorescu A, Stavaru C, Radu DL, Mogos I, Szegli G, Salageanu A.
    Cancer Immunol Immunother; 2004 Dec; 53(12):1146-52. PubMed ID: 15185014
    [Abstract] [Full Text] [Related]

  • 9. Native and inducible levels of natural cytotoxicity in lymph nodes draining mammary carcinoma.
    Kimber I, Moore M, Howell A, Wilkinson MJ.
    Cancer Immunol Immunother; 1983 Dec; 15(1):32-8. PubMed ID: 6553505
    [Abstract] [Full Text] [Related]

  • 10. Dual Functions of T Lymphocytes in Breast Carcinoma: From Immune Protection to Orchestrating Tumor Progression and Metastasis.
    Zareinejad M, Mehdipour F, Roshan-Zamir M, Faghih Z, Ghaderi A.
    Cancers (Basel); 2023 Sep 28; 15(19):. PubMed ID: 37835465
    [Abstract] [Full Text] [Related]

  • 11. Leveraging the Dynamic Immune Environment Triad in Patients with Breast Cancer: Tumour, Lymph Node, and Peripheral Blood.
    Wall I, Boulat V, Shah A, Blenman KRM, Wu Y, Alberts E, Calado DP, Salgado R, Grigoriadis A.
    Cancers (Basel); 2022 Sep 17; 14(18):. PubMed ID: 36139665
    [Abstract] [Full Text] [Related]

  • 12. Immune System Effects on Breast Cancer.
    Amens JN, Bahçecioglu G, Zorlutuna P.
    Cell Mol Bioeng; 2021 Aug 17; 14(4):279-292. PubMed ID: 34295441
    [Abstract] [Full Text] [Related]

  • 13. Tumor infiltrating B-cells signal functional humoral immune responses in breast cancer.
    Garaud S, Buisseret L, Solinas C, Gu-Trantien C, de Wind A, Van den Eynden G, Naveaux C, Lodewyckx JN, Boisson A, Duvillier H, Craciun L, Ameye L, Veys I, Paesmans M, Larsimont D, Piccart-Gebhart M, Willard-Gallo K.
    JCI Insight; 2019 Aug 13; 5(18):. PubMed ID: 31408436
    [Abstract] [Full Text] [Related]

  • 14. Correlation of tumor-infiltrating lymphocytes to histopathological features and molecular phenotypes in canine mammary carcinoma: A morphologic and immunohistochemical morphometric study.
    Kim JH, Chon SK, Im KS, Kim NH, Sur JH.
    Can J Vet Res; 2013 Apr 13; 77(2):142-9. PubMed ID: 24082407
    [Abstract] [Full Text] [Related]

  • 15. Low serum creatine kinase levels in breast cancer patients: a case-control study.
    Pan H, Xia K, Zhou W, Xue J, Liang X, Cheng L, Wu N, Liang M, Wu D, Ling L, Ding Q, Chen L, Zha X, Liu X, Wang S.
    PLoS One; 2013 Apr 13; 8(4):e62112. PubMed ID: 23614022
    [Abstract] [Full Text] [Related]

  • 16. Risk assessment, disease prevention and personalised treatments in breast cancer: is clinically qualified integrative approach in the horizon?
    Golubnitschaja O, Yeghiazaryan K, Costigliola V, Trog D, Braun M, Debald M, Kuhn W, Schild HH.
    EPMA J; 2013 Feb 19; 4(1):6. PubMed ID: 23418957
    [Abstract] [Full Text] [Related]

  • 17. T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers.
    Rody A, Holtrich U, Pusztai L, Liedtke C, Gaetje R, Ruckhaeberle E, Solbach C, Hanker L, Ahr A, Metzler D, Engels K, Karn T, Kaufmann M.
    Breast Cancer Res; 2009 Feb 19; 11(2):R15. PubMed ID: 19272155
    [Abstract] [Full Text] [Related]

  • 18. Association between the expression of IL-10 and T cell activation proteins loss in early breast cancer patients.
    Llanes-Fernández L, Arango-Prado Mdel C, Alcocer-González JM, Guerra-Yi ME, Franco-Odio S, Camacho-Rodríguez R, Madrid-Marina V, Tamez-Guerra R, Rodríguez-Padilla C.
    J Cancer Res Clin Oncol; 2009 Feb 19; 135(2):255-64. PubMed ID: 18651178
    [Abstract] [Full Text] [Related]

  • 19. Intracellular esterase activity in living cells may distinguish between metastatic and tumor-free lymph nodes.
    Afrimzon E, Deutsch A, Shafran Y, Zurgil N, Sandbank J, Pappo I, Deutsch M.
    Clin Exp Metastasis; 2008 Feb 19; 25(3):213-24. PubMed ID: 18197360
    [Abstract] [Full Text] [Related]

  • 20. PTGS2 (COX-2) -765 G > C functional promoter polymorphism and its association with risk and lymph node metastasis in nasopharyngeal carcinoma.
    Ben Nasr H, Chahed K, Bouaouina N, Chouchane L.
    Mol Biol Rep; 2009 Jan 19; 36(1):193-200. PubMed ID: 17968676
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.